Cutler Group LP Zynerba Pharmaceuticals, Inc. Transaction History

Cutler Group LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$1.83 - $3.02 $183 - $302	-100 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$2.88 - $4.3 $4,896 - $7,310	-1,700 Reduced 94.44%	100 $0
Q1 2021 Apr 26, 2021	SELL	$3.33 - $8.76 $6,793 - $17,870	-2,040 Reduced 53.13%	1,800 $8,000
Q3 2020 Oct 27, 2020	BUY	$3.23 - $4.3 $2,390 - $3,182	740 Added 23.87%	3,840 $12,000
Q1 2020 May 07, 2020	SELL	$2.9 - $6.16 $4,930 - $10,472	-1,700 Reduced 35.42%	3,100 $11,000
Q4 2019 Feb 06, 2020	BUY	$5.61 - $8.57 $10,098 - $15,426	1,800 Added 60.0%	4,800 $28,000
Q3 2019 Oct 28, 2019	SELL	$7.56 - $15.44 $27,972 - $57,128	-3,700 Reduced 55.22%	3,000 $22,000
Q2 2019 Aug 09, 2019	BUY	$5.4 - $15.5 $11,340 - $32,550	2,100 Added 45.65%	6,700 $90,000
Q1 2019 May 10, 2019	SELL	$3.6 - $6.22 $16,419 - $28,369	-4,561 Reduced 49.79%	4,600 $24,000
Q4 2018 Feb 05, 2019	SELL	$2.89 - $7.91 $33,700 - $92,238	-11,661 Reduced 56.0%	9,161 $27,000
Q3 2018 Nov 07, 2018	BUY	$5.59 - $10.45 $55,681 - $104,092	9,961 Added 91.71%	20,822 $186,000
Q2 2018 Aug 10, 2018	SELL	$7.98 - $12.39 $10,741 - $16,676	-1,346 Reduced 11.03%	10,861 $105,000
Q1 2018 May 11, 2018	BUY	$8.49 - $13.46 $57,791 - $91,622	6,807 Added 126.06%	12,207 $106,000
Q4 2017 Jan 17, 2018	BUY	$8.69 - $14.59 $8,690 - $14,590	1,000 Added 22.73%	5,400 $67,000
Q3 2017 Oct 17, 2017	BUY	$5.73 - $9.44 $25,212 - $41,536	4,400	4,400 $36,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.